Alessandra Cesano

Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)

Patrick Danaher, Sarah Warren, Rongze Lu et al. · Journal for ImmunoTherapy of Cancer · 2018 · 425 citations · Full text

Life Sciences, Immunology, Oncology +17

Phase I/II Trial of Epratuzumab (Humanized Anti-CD22 Antibody) in Indolent Non-Hodgkin’s Lymphoma

John P. Leonard, Morton Coleman, Jamie Ketas et al. · Journal of Clinical Oncology · 2003 · 252 citations

Pharmacy, Oncology, Pharmacokinetics +17

Epratuzumab, a Humanized Anti-CD22 Antibody, in Aggressive Non-Hodgkin’s Lymphoma

John P. Leonard, Morton Coleman, Jamie Ketas et al. · Clinical Cancer Research · 2004 · 227 citations

Pharmacy, Hematology, Pharmacology +17

Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia

Jayakumar Vadakekolathu, Mark D. Minden, Tressa Hood et al. · Science Translational Medicine · 2020 · 209 citations · Full text

Medicine, Immunology, Oncology +16

Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro properties.

Josette Carnahan, Paul Wang, Richard Kendall et al. · PubMed · 2003 · 184 citations

Pharmacy, Immunology, Oncology +17